Patent Oppositions in organic medicines industry

Explore the competitive field of organic medicines where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in organic medicines technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Last updated on: Aug 20, 2026
CompanyTotal Oppositions
NOVARTIS303
BOEHRINGER INGELHEIM132
NUTRICIA101
PFIZER86
CELGENE70
NESTLE61
JANSSEN PHARMACEUTICA61
AMGEN55
NESTEC51
ASTRAZENECA48

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the organic medicines industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the organic medicines industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Aug 20, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Nicotine Particles And CompositionsPHILIP MORRISAug 19, 2026JAPAN TOBACCO
Multi-Layer Nicotine-Containing Pharmaceutical CompositionMODORAL BRANDSAug 18, 2026PHILIP MORRIS
Aqueous Formulation Comprising 1-(4-{[4-(Dimethylamino)Piperidin-1-Yl]Carbonyl}Phenyl)-3-[4-(4,6-Dimorpholin-4-Yl-1,3,5-Triazin-2-Yl)Phenyl]UreaPFIZERAug 16, 2026ELKINGTON AND FIFE
Sglt-2 Inhibitor For Treating Type 1 Diabetes Mellitus, Type 2 Diabete Mellitus, Impaired Glucose Tolerance Or HyperglycemiaBOEHRINGER INGELHEIMAug 13, 2026TEVA PHARMACEUTICALS
Pharmaceutical CompositionMEXICHEM FLUOR DE CVAug 11, 2026HGF
Pharmaceutical Composition Comprising EnzalutamideSYNTHONAug 11, 2026IPSILON BELGIUM
Solid Forms And Formulations Of (S)-4-(8-Amino-3-(1-(But-2-Ynoyl)Pyrrolidin-2-Yl)Imidazo[1,5-A]Pyrazin-1-Yl)-N-(Pyridin-2-Yl)BenzamideACERTA PHARMAAug 11, 2026HAMM & WITTKOPP
Crystal Forms Of 6-(Cyclopropanecarboxamido)-4-((2-Methoxy-3-(1-Methyl-1H-1,2,4-Triazol-3-Yl)Phenyl)Amino)-N-(Methyl-D3)Pyridazine-3-CarboxamideBRISTOL MYERS SQUIBBAug 11, 2026HAMPTON KNOWLES
Sglt-2 Inhibitor For Treating Type 1 Diabetes Mellitus, Type 2 Diabete Mellitus, Impaired Glucose Tolerance Or HyperglycemiaBOEHRINGER INGELHEIMAug 10, 2026BARDEHLE PAGENBERG
Nutritional ProductUCL BUSINESSAug 7, 2026MOLNIA

To stay ahead in the competitive organic medicines industry, companies are constantly innovating. Here are the top patents facing oppositions in the organic medicines industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Aug 20, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Oct 12, 2022S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS26
Apr 14, 2021Methods And Compositions For Treating CancerJANSSEN ONCOLOGY24
Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA23
Oct 23, 2024New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTIS20
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM19
Oct 11, 2023New UseNOVARTIS19
Mar 8, 2023Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTIS18
Jan 16, 2019(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGEN EUROPE17
Mar 10, 2021Novel Antitumoral Use Of CabazitaxelSANOFI MATURE15
Jan 7, 2026Formulations Of EnzalutamideMEDIVATION PROSTATE THERAPEUTICS14